First Gene Therapy Approved in U.S. (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM
The FDA on Wednesday approved tisagenlecleucel (Kymriah) for patients up to age 25 years with B cell precursor acute lymphoblastic leukemia that has relapsed or not responded …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Gene Therapy | Genetics | Leukemia | Primary Care